|
| 37791419 | Perceptions of Rapid Antiretroviral Therapy Initiation Among Participants of The Netherlands Cohort Study on Acute HIV Infection. | AIDS Res Hum Retroviruses | 2024 |
| 37368521 | The Essential Need for Trust When Transmission Risk Cannot Be Eliminated in HIV-Remission Trials. | Ethics Hum Res | 2023 |
| 37560051 | Corrigendum to "HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption" [J Virus Erad 9 (2) (June 2023) 100331]. | J Virus Erad | 2023 |
| 36949845 | Corrigendum to 'Decision making for invasive and non-invasive optional procedures within an acute HIV research cohort in Bangkok,' [Contemporary Clinical Trials Communication (2023)101054]. | Contemp Clin Trials Commun | 2023 |
| 37450534 | A Paradigm of Investigator Duty to Multiple Stakeholder Participants. | Am J Bioeth | 2023 |
| 37416088 | HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption. | J Virus Erad | 2023 |
| 37074528 | Reporting Individual-Level Research Results from Neurocognitive and Psychological Research in People Living with HIV: Lessons from Dementia Research. | Curr HIV/AIDS Rep | 2023 |
| 37204137 | The Promise and Reality of Public Engagement in the Governance of Human Genome Editing Research. | Am J Bioeth | 2023 |
| 34997386 | Attitudes About Analytic Treatment Interruption (ATI) in HIV Remission Trials with Different Antiretroviral Therapy (ART) Resumption Criteria. | AIDS Behav | 2022 |
| 35769632 | Perceptions of HIV cure and willingness to participate in HIV cure-related trials among people enrolled in the Netherlands cohort study on acute HIV infection. | J Virus Erad | 2022 |
| 35629115 | The Rise of Population Genomic Screening: Characteristics of Current Programs and the Need for Evidence Regarding Optimal Implementation. | J Pers Med | 2022 |
| 35850532 | Scientists' Views on Scientific Self-Governance for Human Genome Editing Research. | Hum Gene Ther | 2022 |
| 36468395 | What Bioethicists Need to Know About the Social Determinants of Health-and Why. | Perspect Biol Med | 2022 |
| 36636463 | Decision making for invasive and non-invasive optional procedures within an acute HIV research cohort in Bangkok. | Contemp Clin Trials Commun | 2022 |
| 35938028 | Public Interest in Population Genetic Screening for Cancer Risk. | Front Genet | 2022 |
| 34059901 | Ethical, legal and social implications of human genome studies in radiation research: a workshop report for studies on atomic bomb survivors at the Radiation Effects Research Foundation. | J Radiat Res | 2021 |
| 33534685 | Beyond the Medical Model: Retooling Bioethics for the Work Ahead. | Am J Bioeth | 2021 |
| 34406038 | The View from the Benches: Scientists' Perspectives on the Uses and Governance of Human Gene-Editing Research. | CRISPR J | 2021 |
| 33966955 | Burden or benefit? Effects of providing education about and the option to request additional genomic findings from diagnostic exome sequencing: A randomized controlled trial. | Patient Educ Couns | 2021 |
| 31312045 | Genomic knowledge in the context of diagnostic exome sequencing: changes over time, persistent subgroup differences, and associations with psychological sequencing outcomes. | Genet Med | 2020 |
| 34737680 | A New Governance Approach to Regulating Human Genome Editing. | N C J Law Technol | 2020 |
| 31857707 | Parents' perceptions of personal utility of exome sequencing results. | Genet Med | 2020 |
| 33165552 | Cohorts as collections of bodies and communities of persons: insights from the SEARCH010/RV254 research cohort. | Int Health | 2020 |
| 33165551 | Recommendations from Thai stakeholders about protecting HIV remission ('cure') trial participants: report from a participatory workshop. | Int Health | 2020 |
| 32596911 | The Future of Bioethics: It Shouldn't Take a Pandemic. | Hastings Cent Rep | 2020 |
| 32617433 | Parallel but connected: Nuances of conducting behavioral and social science research alongside ethically challenging HIV remission trials. | Contemp Clin Trials Commun | 2020 |
| 32457518 | Development and validation of a measure of comprehension of genomic screening-negative results (CoG-NR). | Eur J Hum Genet | 2020 |
| 32125936 | Assessing the implications of positive genomic screening results. | Per Med | 2020 |
| 29237332 | Traditional, complementary, and alternative medical cures for HIV: rationale and implications for HIV cure research. | Glob Public Health | 2019 |
| 30237575 | Factors influencing NCGENES research participants' requests for non-medically actionable secondary findings. | Genet Med | 2019 |
| 29875426 | Returning negative results to individuals in a genomic screening program: lessons learned. | Genet Med | 2019 |
| 30009625 | Indirect Benefits in HIV Cure Clinical Research: A Qualitative Analysis. | AIDS Res Hum Retroviruses | 2019 |
| 31341244 | Correction: Genomic knowledge in the context of diagnostic exome sequencing: changes over time, persistent subgroup differences, and associations with psychological sequencing outcomes. | Genet Med | 2019 |
| 30869203 | Going off antiretroviral treatment in a closely monitored HIV "cure" trial: longitudinal assessments of acutely diagnosed trial participants and decliners. | J Int AIDS Soc | 2019 |
| 31108576 | The Role of Inclusion Benefits in Ethics Committee Assessment of Research Studies. | Ethics Hum Res | 2019 |
| 30535615 | How Biomedical HIV Prevention Trials Incorporate Behavioral and Social Sciences Research: A Typology of Approaches. | AIDS Behav | 2019 |
| 28858330 | Navigating the research-clinical interface in genomic medicine: analysis from the CSER Consortium. | Genet Med | 2018 |
| 30174214 | Ethical considerations in global HIV phylogenetic research. | Lancet HIV | 2018 |
| 31021238 | Is Enhancement the Price of Prevention in Human Gene Editing? | CRISPR J | 2018 |
| 29621446 | Grudging Trust and the Limits of Trustworthy Biorepository Curation. | Am J Bioeth | 2018 |
| 29593351 | "Possibly positive or certainly uncertain?": participants' responses to uncertain diagnostic results from exome sequencing. | Genet Med | 2018 |
| 29261173 | The who, what, and why of research participants' intentions to request a broad range of secondary findings in a diagnostic genomic sequencing study. | Genet Med | 2018 |
| 29127137 | Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment. | J Med Ethics | 2018 |
| 29215654 | Age and perceived risks and benefits of preventive genomic screening. | Genet Med | 2018 |
| 27490114 | Is "incidental finding" the best term?: a study of patients' preferences. | Genet Med | 2017 |
| 30086550 | Examining the Cascade of Participant Attrition in a Genomic Medicine Research Study: Barriers and Facilitators to Achieving Diversity. | Public Health Genomics | 2017 |
| 28118036 | "Forward-Thinking" in U.S. Biobanking. | Genet Test Mol Biomarkers | 2017 |
| 28260941 | Is there evidence that we should screen the general population for Lynch syndrome with genetic testing? A systematic review. | Pharmgenomics Pers Med | 2017 |
| 29069655 | Online Education and e-Consent for GeneScreen, a Preventive Genomic Screening Study. | Public Health Genomics | 2017 |
| 28837373 | Informed Consent and Decision Making Among Participants in Novel-Design Phase I Oncology Trials. | J Oncol Pract | 2017 |